MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track soft-tissue and tumors. These capabilities allow MRIdian to deliver accurate doses of radiation to the tumor while protecting nearby healthy tissues and vulnerable structures, enabling personalized, non-invasive treatment. The use of MRIdian is associated with improved patient outcomes, shorter treatment durations, and reduced treatment-related side effects.
Stanford Health Care is internationally renowned for its expertise in cancer treatment and translating important medical breakthroughs into patient care. As a leading academic medical center, Stanford Health Care provides state-of-the-art technologies and treatments to help advance care and improve outcomes for patients.
"We are proud to announce our strategic agreement with Stanford Health Care," said
View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-announces-collaboration-with-stanford-health-care-300917412.html
Investor Relations: Michaella Gallina, Chief of Staff, Head of Investor Relations, ViewRay, Inc., 1-844-MRIdian (674-3426), Email: firstname.lastname@example.org; Media Enquiries: Karen Hackstaff, Vice President, Strategy and Brand, ViewRay, Inc., Phone: +1 408-242-2994, Email: email@example.com